Sertraline Hydrochloride Tablet
Product Images NDC 43063-033

2 FDA label images from Pd-rx Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 43063-033). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063033 Label (43063033)

43063033 Label (43063033)
Label for Sertraline Hydrochloride 50 mg oral tablets, 90 count, manufactured by PD-Rx Pharmaceuticals, Inc. The label includes the NDC 43063-033-90, expiration date 07/2021, lot number G19E77, and reorder number 110236. It carries a warning to keep out of reach of children and advises consulting the package insert for dosage and storage information. The label displays drug identification, barcode, and QR code.*
FDA Label Image

Chemical Structure (Sertraline Str)

Chemical Structure (Sertraline Str)
Chemical structure of Sertraline Hydrochloride, showing its molecular framework including aromatic rings, chlorine atoms, and an amine group as labeled in the diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.